New paper out from the CJ lab! Have a look if you are interested in knowing more about SARS-CoV-2 omicron mouse models!! Great collaborative study Patricia Ogger wendybarclay NHLI

Peter Openshaw starts the RSV vaccine session - it’s been a long time coming but MAbs and vaccines are having meaningful impacts on RSV disease.

The ENC/ASC is back again this year at #ESCMIDGlobal 2024 . Watch the online videos where our partners and affiliates get a chance to share about their missions and activities. Find the full list of participating partners here: eccmid.org/congress-infor…
#ESCMIDGlobal

I heard someone call #ECCMID2024 'the Glastonbury of Infectious Diseases and Microbiology '

Good analogy in many ways!!

#escmidglobal2024

Agree with all that Michael Worobey says 👇

The story of frequent persistence of #SARSCoV2 in multiple organs after mild Covid keeps getting stronger, and correlates (odds ratio >5) with symptoms of #LongCovid
🆕The Lancet Infectious Diseases
thelancet.com/journals/lanin…

Viral RNA was found in liver, kidney, stomach, intestine, brain, blood vessel, lung, breast, skin, and thyroid. vRNA was associated long COVID Sx (OR 5·17, p<0·0001). Patients with higher virus load had a higher likelihood of developing long COVID.

Source: ‘Large-scale phenotyping of patients with #LongCOVID post-hospitalization reveals mechanistic subtypes of disease.’
nature.
Research team: Professor Peter Openshaw et al NHLI

nature.com/articles/s4159…

'Findings from the largest UK study of patients hospitalised with #SARSCoV2 infection show that people with #LongCOVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies.' UK Research and Innovation
ukri.org/news/long-covi…

Eswatini introduced the HPV Vaccine in June 2023. Within the first 3 weeks, nearly 50,000 girls were vaccinated, preventing as many as 30% of Eswatini’s future cervical cancer cases. Today, the mission continues, with a focus on in-school vaccinations of children ages 9-14 to

A robust study with 1 million individuals shows that #COVID vaccination reduces the risk of hospitalization and death, especially in at-risk populations. Get the up-to-date COVID #vaccine . skepticalraptor.com/skepticalrapto…

'We hope that our work opens the way to the development of specific tests and treatments for the various types of long COVID and believe that a ‘one size fits all’ approach to treatment may not work' Peter Openshaw

imperial.ac.uk/news/252415/lo…

Our latest #LongCovid research from PHOSP-COVID study & ISARIC4C has found inflammatory patterns across different symptoms. The work brings us closer to understanding long COVID and finding treatments. Thanks to all co-authors Peter Openshaw Ryan Thwaites & Claudia Efstathiou

'With 1 in 10 #SARSCoV2 infections leading to #LongCOVID and ~65million people globally suffering ongoing symptoms, we urgently need more research to understand this condition. At the moment, it’s very hard to diagnose and treat'. Peter Openshaw NHLI
ukri.org/news/long-covi…

Prospective, longitudinal data with a contemporaneous non-cancer cohort has enable us to make important novel observations in regard to cancer patients on treatment & admitted with COVID Lance Turtle ⬇️ this demonstrates power of national pandemic planning ISARIC ISARIC4C

This year's International Day of Immunology will be Monday, April 29th! This year's theme is #ImmunityAndAging !

Register for our #DayofImmunology webinar: loom.ly/M63fa6w

Learn about our social media contest for national and regional societies: loom.ly/yWRSIP0

We are hosting a free public talk by DAME SARAH GILBERT at Imperial College London on 'Vaccine development in a pandemic'.

All welcome, register here: eventbrite.co.uk/e/vaccine-deve…

Please RT

We’re pleased to share our latest analysis of the ISARIC4C CCP-UK dataset of patients hospitalised with COVID in the UK, looking at patients having treatment for cancer over the first two years of the pandemic.
sciencedirect.com/science/articl…

The data highlight the robust working of our immune system, with concentration on conserved parts of the pathohen. SARS-CoV-2 has many epitiopes and will not overcome vaccine or infection induced immunity.

x.com/Marc_Veld/stat…
10/10